The Board of Directors appointed Ms. Greenberg as a director of the Company effective July 9, 2021. Ms. Greenberg is Co-Founder, Board Member and Executive Managing Director of Discovery Labs and its sister operating company, Center for Breakthrough Medicines, a biopharma real estate and services platform enabling the path to commercialization for novel cell and gene therapies. Ms. Greenberg’s diverse experience spans over two decades in real estate private equity where she managed several REITs, including time as Chief Financial Officer and Senior Vice President at ING Clarion Partners, Senior Vice President at Exeter Property Group, and Chief Financial Officer and Principal at CBRE Global Investors. Prior to her time in private equity, Ms. Greenberg worked as an investment banker at Morgan Stanley and Merrill Lynch. Ms. Greenberg started her career in public accounting at Deloitte and has an MBA from Wharton.
Current role
Independent Board Member at Edita Food Industries
Independent Board Member at Edita Food Industries
Independent Board Member at Global Yatirim Holding
Independent Board Member at BlueBay Asset Management
Independent Board Member at STO Building Group